| Autor: |
Naveed, Safoora, Mashhood, Asher Ahmed, Malik, Sakina Sadiq, Khalid, Abrar Ahmad, Anjum, Muhammad, Ellahi, Ayesha, Shaikh, Zafar Iqbal |
| Předmět: |
|
| Zdroj: |
Journal of Pakistan Association of Dermatologists; Jul-Sep2023, Vol. 33 Issue 3, p827-831, 5p |
| Abstrakt: |
Objective The aim of the study is to compare the efficacy of topical calcipotriol (0.005%) and topical anthralin (0.5%) in treatment of Chronic Plaque Psoriasis (CPP). Methods This randomized, interventional study was conducted at Pak Emirates Military Hospital, Rawalpindi and Combined Military Hospital, Rawalpindi for 6-month period (10th January 2020 to 10th July 2020). A sample of 186 patients was randomly distributed in two groups. In group A, patients applied topical anthralin (0.5%) every night for 12 weeks. In group B, patients applied topical calcipotriol (0.005%) every night for 12 weeks. The follow up period was 12 weeks and assessment of the efficacy was done at 4, 8 and 12 weeks by utilizing PASI score. Results The age range of the individuals was from 15 to 50 years. The average duration of presenting complaint for Group A was 8.903±1.85 months while for Group B was 9.193±2.58 months. In Group A, the average PASI score before and after the treatment was 16.22±3.02 and 4.784±3.28 respectively and in Group B the average PASI score before and after the treatment was 16.03±2.09 and 2.376±2.39 respectively. The number of male patients in each group was more than female. Efficacy i.e. reduction in PASI score by 75% was seen in 21.5% patients of Group A as compared to 43% in Group B (p=0.001). Conclusion In conclusion, 0.005% calcipotriol is considerably more efficacious than 0.5% anthraline in bringing disease improvement and patient satisfaction than 0.5% anthraline. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
